Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Papers: 10 Sep 2012 - 17 Sep 2012
Preferential Use of Public TCR during Autoimmune Encephalomyelitis.
Papers: 22 Apr 2013 - 29 Apr 2013
Papers: 22 Oct 2012 - 29 Oct 2012
Novel Mouse Model of MS Allows Neuroprotective Drug Testing
Oral Cannabinoid Dronabinol Doesn’t Modify Disease in Progressive MS
Papers: 27 Aug 2012 - 3 Sep 2012
Papers: 30 Jul 2012 - 6 Aug 2012
MS Patient, Ph.D.: MRI Reading: Art or Science?
MS Research Roundup: November 11, 2014
Papers: 21 Nov 2015 - 28 Nov 2015
Episode 77 with Dr. Annette Langer-Gould on MS, pregnancy and breastfeeding
Sex Differences in MS Are Genetic, Not Just Hormonal
Publication guidelines for refereeing and reporting on animal use in experimental autoimmune encephalomyelitis.
Papers: 21 Jan 2013 - 28 Jan 2013
Papers: 25 Jul 2014 - 1 Aug 2014
One year activity on subtraction MRI predicts subsequent 4 year activity and progression in multiple sclerosis.
Papers: 11 Mar 2013 - 18 Mar 2013
Switches to Fingolimod, Natalizumab Show Similar Efficacy
Advanced MRI and staging of multiple sclerosis lesions.
Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells.
MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals.
Papers: 22 Aug 2014 - 29 Aug 2014
Papers: 23 Jan 2015 - 30 Jan 2015
Papers: 24 Dec 2012 - 31 Dec 2012
Pages
« first
‹ previous
…
21
22
23
24
25
26
27
28
29
…
next ›
last »
